Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alpha Innotech was a leading provider of digital imaging and analysis systems for the life science research market. The company specialized in systems for genomic and proteomic analysis, including gel documentation, chemiluminescence imaging, and fluorescence detection. Their flagship products, such as the FluorChem and AlphaImager lines, enabled researchers to visualize and quantify DNA, RNA, and proteins. Alpha Innotech's technology was widely used in academic, pharmaceutical, and biotechnology laboratories worldwide. The company played a significant role in the industry's transition from traditional X-ray film to digital imaging for Western blots and gel electrophoresis. In 2009, Alpha Innotech was acquired by Cell Biosciences, which later rebranded as ProteinSimple and was subsequently acquired by Bio-Techne.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alpha Innotech.